Selected publications

*indicates equal contribution and # indicates corresponding authorship.

  • Yasser Riazalhosseini# and Mark Lathrop# (2016): Precision medicine from the renal cancer genome. Nature Reviews Nephrology (in press).
  • Pudchalaluck Panichnantakul, Mathieu Bourgey, Alexandre Montpetit, Guillaume Bourque, Yasser Riazalhosseini# (2016): RNA-seq as a tool to study the tumor microenvironment. Methods in Molecular Biology 1458:311-37.
  • Pouria Jandaghi, Hamed S. Najafabadi, Andrea S. Bauer, Andreas I. Papadakis, Matteo Fassan, Anita Hall, Anie Monast, Magnus von Knebel Doeberitz, John P. Neoptolemos, Eithne Costello, William Greenhalf, Aldo Scarpa, Bence Sipos, Daniel Auld, Mark Lathrop, Morag Park, Markus W. Büchler, Oliver Strobel, Thilo Hackert, Nathalia A. Giese, George Zogopoulos, Veena Sangwan, Sidong Huang, Yasser Riazalhosseini#, Jörg D. Hoheisel (2016): Expression of DRD2 is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice. Gastroenterology, doi: 10.1053/j.gastro.2016.08.040.
  • Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri, Rebecca Johnston, Lauren Chong, Jasleen Grewal, Stephen Yu, Daniel Fornika, Kevin Bushell, Torsten Holm Nielsen, Tina Petrogiannis-Haliotis, Michael Crump, Axel Tosikyan, Bruno Grande, David MacDonald, Caroline Rousseau, Maryam Bayat, Remi Froment, Yury Monczak, Kathleen Klein Oros, Celia Greenwood, Yasser Riazalhosseini, Madeleine Arseneault, Errol Camiglioglu, André Constantin, Qiang Pan-Hammarstrom, Koren K. Mann and Nathalie Johnson (2015): Genetic landscapes of relapsed and refractory diffuse large B cell lymphomas. Clinical Cancer Research Dec 8. pii: clincanres.2123.2015.
  • Gurpreet Manku, Aurelie Hueso, Fadi Brimo, Peter Chan, Pilar Gonzalez-Peramato, Nada Jabado, Mathieu Bourgey, Tenzin Gayden, Yasser Riazalhosseini and Martine Culty (2015): Identification of genes overexpressed in seminoma and downregulated during genotype differentiation as potential players in the origions of testicular cancer. Andrology, doi: 10.1111/andr.12122.
  • Ataei-Kachouei M, Nadaf J, Akbari MT, Atri M, Majewski J, Riazalhosseini Y, Garshasbi M (2015): Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing. Iran J Public Health. 44(10):1348-52.
  • Evgeny A. Moskalev, Pouria Jandaghi, Mahdi Fallah, Mehdi Manoochehri, Sandeep K. Botla, Oleg V. Kolychev, Evgeny A. Nikitin, Vladymyr V. Bubnov, Oliver Strobel, Thilo Hackert, Markus W. Büchler, Nathalia Giese, Andrea Bauer, Thomas Muley, Arne Warth, Peter Schirmacher, Florian Haller, Jörg D. Hoheisel and Yasser Riazalhosseini#. (2015): GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers. Oncotarget 6(6):4418-27.
  • Pouria Jandaghi, Jörg D. Hoheisel and Yasser Riazalhosseini# (2015): GHSR hypermethylation: a promising pan-cancer marker. Cell Cycle 14(5):689-90.
  • Karim Labreche*, Aurélie Kamoun*, Daniel Chubb, Eric Letouzé, Yasser Riazalhosseini, Sara E Dobbins, Nabila Elarouci, Francois Ducray, Aurélien de Reyniès, Diana Zelenika, Christopher P Wardell, Mathew Frampton, Olivier Saulnier, Tomi Pastinen, Sabrina Hallout, Dominique Figarella-Branger, Caroline Dehais, Ahmed Idbaih, Jean-Yves Delattre, G. Mark Lathrop, Marc Sanson and Richard S Houlston (2015): TCF12 is mutated in anaplastic oligodendroglioma. Nature Communications 6:7207. doi: 10.1038/ncomms8207.
  • Ghislaine Scelo*, Yasser Riazalhosseini*, Liliana Greger*, Louis Letourneau*, Mar Gonzàlez-Porta*, Magdalena B Wozniak, Mathieu Bourgey, Patricia Harnden, Lars Egevad, Sharon M Jackson, Mehran Karimzadeh, Madeleine Arseneault, Pierre Lepage, Alexandre How-Kit, Antoine Daunay, Victor Renault, Hélène Blanché, Emmanuel Tubacher, Jeremy Sehmoun, Juris Viksna, Edgars Celms, Martins Opmanis, Andris Zarins, Naveen S Vasudev, Morag Seywright, Behnoush Abedi-Ardekani, Christine Carreira, Peter J Selby, Jon J Cartledge, Graham Byrnes, Jiri Zavadil, Jing Su, Ivana Holcatova, Antonin Brisuda, David Zaridze, Anush Moukeria, Lenka Foretova, Marie Navratilova, Dana Mates, Viorel Jinga, Artem Artemov, Artem Nedoluzhko, Alexander Mazur, Sergey Rastorguev, Eugenia Boulygina, Simon Heath, Marta Gut, Marie-Therese Bihoreau, Doris Lechner, Mario Foglio, Ivo G Gut, Konstantin Skryabin, Egor Prokhortchouk, Anne Cambon-Thomsen, Johan Rung, Guillaume Bourque, Paul Brennan, Jörg Tost, Rosamonde E Banks, Alvis Brazma, and G Mark Lathrop. (2014): Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Nature Communications 5:5135 doi: 10.1038/ncomms6135.
  • Leora Witkowski, Jian Carrot-Zhang, Steffen Albrecht, Somayyeh Fahiminiya, Nancy Hamel, Eva Tomiak, David Grynspan, Emmanouil Saloustros, Javad Nadaf, Barbara Rivera, Catherine Gilpin, Ester Castellsagué, Rachel Silva-Smith, François Plourde, Mona Wu, Avi Saskin, Madeleine Arseneault, Rouzan G Karabakhtsian, Elizabeth A Reilly, Frederick R Ueland, Anna Margiolaki, Kitty Pavlakis, Sharon M Castellino, Janez Lamovec, Helen J Mackay, Lawrence M Roth, Thomas M Ulbright, Tracey A Bender, Vassilis Georgoulias, Michel Longy, Andrew Berchuck, Marc Tischkowitz, Inga Nagel, Reiner Siebert, Colin J R Stewart, Jocelyne Arseneau, W Glenn McCluggage, Blaise A Clarke, Yasser Riazalhosseini, Martin Hasselblatt, Jacek Majewski and William D Foulkes (2014): Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nature Genetics 46 (5): 438-43.
  • Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril, Neil E Caporaso, Mary L McMaster, Michael Cullen, Zhaoming Wang, Xijun Zhang, NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, French Familial Melanoma Study Group, William Bruno, Lorenza Pastorino, Paola Queirolo, Jose Banuls-Roca, Zaida Garcia-Casado, Amaury Vaysse, Hamida Mohamdi, Yasser Riazalhosseini, Mario Foglio, Fanélie Jouenne, Xing Hua, Paula L Hyland, Jinhu Yin, Haritha Vallabhaneni, Weihang Chai, Paola Minghetti, Cristina Pellegrini, Sarangan Ravichandran, Alexander Eggermont, Mark Lathrop, Ketty Peris, Giovanna Bianchi Scarra, Giorgio Landi, Sharon A Savage, Joshua N Sampson, Ji He, Meredith Yeager, Lynn R Goldin, Florence Demenais, Stephen J Chanock, Margaret A Tucker, Alisa M Goldstein, Yie Liu and Maria Teresa Landi (2014) Germline POT1 mutations predispose to familial cutaneous malignant melanoma. Nature Genetics 46 (5): 482-86.
  • Tofigh A, Suderman M, Paquet E, Livingstone J, Bertos N, Saleh S, Zhao H, Souleimanova M, Cory S, Lesurf R, Shahalizadeh S, Garcia Lopez N, Riazalhosseini Y., Omeroglu A, Ursini-Siegel J, Park M, Dumeaux V and Hallett M. (2014): The prognostic ease and difficulty of invasive breast carcinoma. Cell Reports 9(1): 129-42.
  • Florian Haller, Jitao David Zhang, Evgeny A. Moskalev, Alexander Braun, Claudia Otto, Helene Geddert, Yasser Riazalhosseini, Aoife Ward, Aleksandra Balwierz, Inga-Marie Schaefer, Silke Cameron, B. Michael Ghadimi, Abbas Agaimy, Jonathan A. Fletcher, Jörg Hoheisel, Arndt Hartmann, Martin Werner, Stefan Wiemann and Özgür Sahin (2014): Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor. International Journal of Cancer. doi: 10.1002/ijc.29088
  • Myriam Chevarie-Davis, Yasser Riazalhosseini, Madeleine Arseneault, Armen Aprikian, Wassim Kassouf, Simon Tanguay, Mathieu Latour and Fadi Brimo (2014): The morphologic and immunohistochemical spectrum of papillary renal cell carcinoma: study including 132 cases with pure type 1 and type 2 morphology as well as tumors with overlapping features. American Journal of Surgical Pathology 38(7):887-94.
  • Maria Shahmoradgoli*, Yasser Riazalhosseini*, Daniel Haag, Natalia Becker, Volker Hovestadt, Stefanie Heck, Hans-Peter Sinn, Andreas Schneeweiss, Otto Mannherz, Özgür Sahin and Peter Lichter (2013): Identification of PPP1R15B as a survival factor in Estrogen Receptor α-positive breast cancer cells. International Journal of Cancer 132(11):2714-2719.
  • Sandeep Kumar Botla, Amin Moghaddas Gholami, Mahdi Malekpour, Evgeny A. Moskalev, Mahdi Fallah, Pouria Jandaghi, Ali Aghajani, Irina S. Bondar, Ramesh Omranipour, Fatemeh Malekpour, Abbas Mohajeri, Azin Jahangiri Babadi, Özgür Sahin, Vladimir V. Bubnov, Hossein Najmabadi, Jörg D. Hoheisel and Yasser Riazalhosseini#. (2012): Diagnostic values of GHSR DNA methylation pattern in breast cancer. Breast Cancer Resrach and Treatment 135(3): 705-713.
  • Pedro de Souza Rocha Simonini, Achim Breiling, Nibedita Gupta, Mahdi Malekpour, Mahmoud Youns, Ramesh Omranipour, Fatemeh Malekpour, Stefano Volinia, Carlo M. Croce, Hossein Najmabadi, Sven Diederichs, Özgür Sahin, Doris Mayer, Frank Lyko, Jörg D. Hoheisel and Yasser Riazalhosseini#. (2010): Epigenetically de-regulated microRNA-375 is involved in a positive feedback loop with Estrogen Receptor α in breast cancer cells. Cancer Research 70(22): 9175-9184.
  • Uhlmann, S., Zhang, J.D., Schwäger, A., Mannsperger, H., Riazalhosseini, Y., Burmester, S., Ward, A., Korf, U., Wiemann, S., Sahin, Ö. (2010): miR-200bc/429 cluster of miR-200 family differentially regulates proliferation and EGF-driven invasion than miR-200a/141 by targeting PLCγ1 in breast cancer. Oncogene 29(30): 4297-4306.
  • Yasser Riazalhosseini# and Jörg D. Hoheisel (2008): Do we use the appropriate controls for the identification of informative methylation markers for early cancer detection? Genome Biology 9(11), 405.